JULEE KAULING: Open Payments
NPI 1437108909 · ROMEOVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,301 in 36 payments from 10 companies in 2025. Trend: 2023 $797 · 2024 $867 · 2025 $2,301
Food & beverage: $2,301
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $676 |
| ABBVIE INC. | 15 | $490 |
| Otsuka America Pharmaceutical, Inc. | 3 | $365 |
| Axsome Therapeutics, Inc. | 2 | $147 |
| Braeburn Inc. | 1 | $134 |
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $123 |
| Indivior Inc. | 1 | $103 |
| Neuronetics, Inc. | 1 | $4 |
Products named: CAPLYTA, VRAYLAR, ABILIFY MAINTENA, Auvelity, BRIXADI, SPRAVATO, REXULTI, FANAPT.
Industry payments across IL — which companies pay providers there.
